This compound is primarily utilized in the field of pharmaceutical research and development, particularly as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a fluorophenyl group and a methoxyethylamine moiety, makes it a valuable building block for designing molecules with potential therapeutic effects. It is often explored in the development of drugs targeting the central nervous system, such as antidepressants, antipsychotics, or anxiolytics, due to its ability to interact with neurotransmitter systems. Additionally, it may be investigated for its potential use in creating compounds with anti-inflammatory or analgesic properties. Its hydrochloride form ensures stability and solubility, making it suitable for further chemical modifications and formulation studies.